2026-02-06 03:00:54
Denosumab is an important biologic agent widely used in the treatment of osteoporosis, giant cell tumors of bone, and bone-related events caused by bone metastasis of solid tumors. By inhibiting the activity and survival of osteoclasts, it effectively increases bone density and reduces the risk of fractures, playing a key role in the treatment of skeletal diseases. Although denosumab has a good overall safety profile, like all drugs, it may also bring some potentially serious side effects, especially in specific situations such as long-term use or individual sensitivity. Therefore, both patients and doctors need to have a full understanding of this so as to identify and manage it in a timely manner.